value of consideration which is the basis giving the highest result of transaction. The outcome is calculated from the Company’s consolidated financial statements in interim review version for the 9-month
of consideration basis, calculated from the Company’s reviewed consolidated financial statements for 9-month period as of 30 September 2017. Therefore, the entering of transaction when combined with
subsidiaries (Consolidated) realized net loss of 72.32 million Baht in 2018, and net loss of 72.28 million Baht in 2017. The Company’s net loss has increased 0.04 million Baht or 0.06 % from the previous year
) 84.18 116.40 Earnings per share (Baht per share) (0.030) (0.015) 0.0149 99.40 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of 156.50 million Baht in 2019, and net loss
) (11.18) Net Profit (Loss) (43.62) (6.22) 37.40 601.29 Earnings per share (Baht per share) (0.008) (0.001) 0.007 700.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of
) 12.63 61.55 Net Profit (Loss) (79.97) (22.90) 57.07 249.21 Earnings per share (Baht per share) (0.0153) (0.0040) 0.0113 282.10 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net
statement for Year 2020 ended as of December 31, 2020, (1 January – 31 December), which details are as following Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net profit of 488.52
Limited ทะเบียนเลขที่ 0107556000311 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net profit of 423.62 million Baht in 2021, and net profit of 488.52 million Baht in 2020. The
revenues from sales and services from distributor of medical devices and equipment at the 3Q/2017 was 87 million compared to the 2Q/2017. This is because medical devices have been delivery since end of 2Q